2SHB 2145 — Protecting patient access to discounted medications and health care services through Washington's health care safety net by preventing manufacturer limitations on the 340B drug pricing program.
Did not pass — the 2025–26 session has ended
- Sponsor
- Thai
- Introduced
- February 9, 2026
- Status
- H Rules R
- Last action
- Referred to Rules 2 Review. (February 9, 2026)
What this bill does
Prohibits a manufacturer or a distributor or third-party logistics provider of a manufacturer's drugs from restricting the acquisition of drugs under the 340B Drug Pricing Program (340B Program). Prohibits a manufacturer or a distributor or third-party logistics provider of a manufacturer's drugs from requiring a 340B Program covered entity to submit data as a condition for allowing the acquisition of drugs under the 340B Program.
From the Washington State Legislature's nonpartisan staff bill analysis. Read the full analysis ↗
Track 2SHB 2145 on OlympiaTrack
A free account adds a plain-English AI summary, the full hearing and amendment record, who testified, and roll calls by member. Track the subject and get an alert if it comes back next session.
Create a free accountOther bills sponsored by Thai
- 2SHB 1207 — Concerning superior court clerk fees.
- 2SHB 1359 — Reviewing laws related to criminal insanity and competency to stand trial.
- 2SHB 1614 — Modifying the capital gains tax.
- E3SHB 1634 — Providing school districts and public schools with assistance to coordinate comprehensive behavioral health supports for students.
- ESHB 1718 — Concerning well-being programs for certain health care professionals.
All 2025-26 Washington State bills →
Source: the Washington State Legislature. OlympiaTrack is an independent bill-tracking service and is not affiliated with the Legislature. View on leg.wa.gov ↗